Pharmacokinetics of metformin in pediatric type 2 diabetic and healthy adult subjects.

被引：9
|
作者：
Gao, X
Christensen, M
Burghen, GA
Velasquez-Mieyer, P
Moore, KT
Donahue, SR
Reeves, RA
Turner, KC
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[2] Univ Tennessee, Knoxville, TN 37996 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 73卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(03)90526-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P46 / P46
页数：1
相关论文
共 50 条
  • [21] INDUCTIVE EFFECT OF RIFAMPIN ON THE PHARMACOKINETICS OF VORICONAZOLE IN HEALTHY SUBJECTS.
    Lee, S.
    Shin, D.
    Kim, S.
    Ji, S. C.
    Yoon, S. H.
    Cho, J. Y.
    Shin, S. G.
    Jang, I. J.
    Yu, K. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S3 - S4
  • [22] Repaglinide pharmacokinetics in healthy & chronic liver disease subjects.
    Hatorp, V
    Haug-Pihale, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 187 - 187
  • [23] Comparison of the pharmacokinetics of acebutolol in elderly and young healthy subjects.
    Sohn, DR
    Lee, YG
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (04) : S81 - S81
  • [24] Effect of rifampin on the pharmacokinetics of rosiglitazone in Korean healthy subjects.
    Park, J
    Kim, K
    Jung, W
    Kim, S
    Shin, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P34 - P34
  • [25] Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone in healthy subjects.
    Lebrun-Vignes, B
    Chosidow, O
    Diquet, B
    Levron, JC
    Herson, S
    Corbrion-Archer, V
    Puech, AJ
    Warot, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 683 - 683
  • [26] Lack of effect of aprepitant on digoxin pharmacokinetics in healthy subjects.
    Lee, Y
    Orlowski, LH
    Michiels, N
    Petty, KJ
    Goldberg, MR
    Dru, J
    Chavez-Eng, CM
    Constanzer, M
    Murphy, G
    Gottesdiener, K
    Hesney, M
    Feuring, M
    Wehling, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P66 - P66
  • [27] EFFECTS OF DRONEDARONE ON PHARMACOKINETICS AND PHARMACODYNAMICS OF LOSARTAN IN HEALTHY SUBJECTS.
    Bonnet, Denis
    Galleyrand, Jacques
    Brunet, Aurelie
    Sultan, Eric
    Gaud, Christine
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1080 - 1080
  • [28] EFFECT OF ACTIVATED CHARCOAL ON THE PHARMACOKINETICS OF APIXABAN IN HEALTHY SUBJECTS.
    Wang, X.
    Tirucherai, G.
    Pannacciulli, N.
    Wang, J.
    Elsrougy, A.
    Teslenko, V.
    Chang, M.
    Zhang, D.
    Frost, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S41 - S41
  • [29] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF INHALED REMDESIVIR IN HEALTHY SUBJECTS.
    Humeniuk, R.
    Juneja, K.
    Chen, S.
    Ellis, S.
    Xiao, D.
    Share, A.
    Johnston, M.
    Davies, S.
    Blair, C.
    Osinusi, A.
    Girish, S.
    Palaparthy, R.
    Dresser, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S26 - S26
  • [30] Effect of combination glipizide GITS/Metformin on fibrinolytic and metabolic parameters in poorly controlled, Type 2 diabetic subjects.
    Sobel, BE
    Schneider, DJ
    Cefalu, WT
    DIABETOLOGIA, 2002, 45 : A252 - A253
12345